相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tetraspanin CD151 maintains vascular stability by balancing the forces of cell adhesion and cytoskeletal tension
Feng Zhang et al.
BLOOD (2011)
A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer
Sunjoo Ahn et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Biological Activity of 4-Substituted Methoxybenzoyl-Aryl-Thiazole: An Active Microtubule Inhibitor
Chien-Ming Li et al.
CANCER RESEARCH (2011)
New drugs in melanoma: It's a whole new world
Alexander M. M. Eggermont et al.
EUROPEAN JOURNAL OF CANCER (2011)
PLX4032 and melanoma: resistance, expectations and uncertainty
Dimitrios H. Roukos
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Drug Metabolism and Pharmacokinetics of 4-Substituted Methoxybenzoyl-aryl-thiazoles
Chien-Ming Li et al.
DRUG METABOLISM AND DISPOSITION (2010)
Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway
Yasuhiro Kidera et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Discovery of Novel 2-Aryl-4-benzoyl-imidazoles Targeting the Colchicines Binding Site in Tubulin As Potential Anticancer Agents
Jianjun Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
MVL-PLA2, a Snake Venom Phospholipase A2, Inhibits Angiogenesis through an Increase in Microtubule Dynamics and Disorganization of Focal Adhesions
Amine Bazaa et al.
PLOS ONE (2010)
Identifying Novel Molecular Structures for Advanced Melanoma by Ligand-Based Virtual Screening
Zhao Wang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure-Activity Relationships
Yan Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3β, 17α, 20-triol and their bioactivity in melanoma cells
Michal A. Zmijewski et al.
STEROIDS (2009)
Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota
Wei Guo et al.
CANCER RESEARCH (2008)
A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors
Elizabeth Fox et al.
CLINICAL CANCER RESEARCH (2008)
The multidrug transporter P-glycoprotein: A mediator of melanoma invasion?
Marisa Colone et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
The tyrosine kinase inhibitor cediranib for non-small cell lung cancer and other thoracic malignancies
Petros Nikolinakos et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin
Bhabatarak Bhattacharyya et al.
MEDICINAL RESEARCH REVIEWS (2008)
Synthesis and antiproliferative activity of thiazolidine analogs for melanoma
Wei Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models
Jianping Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Melanoma biology and new targeted therapy
Vanessa Gray-Schopfer et al.
NATURE (2007)
GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis
Lei Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Pseudolarix acid B, a new tubulin-binding agent, inhibits angiogenesis by interacting with a novel binding site on tubulin
YG Tong et al.
MOLECULAR PHARMACOLOGY (2006)
Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors
LV Beerepoot et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemotherapy for metastatic melanoma
Marta Mandara et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Colchicine and 2-methoxyestradiol inhibit human angiogenesis
SJ Stafford et al.
JOURNAL OF SURGICAL RESEARCH (2005)
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
RBG Ravelli et al.
NATURE (2004)
Species differences in troxacitabine pharmacokinetics and pharmacodynamics: Implications for clinical development
H Gourdeau et al.
CLINICAL CANCER RESEARCH (2004)
Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material
JE Diestra et al.
JOURNAL OF PATHOLOGY (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
分享论文
